Advertisement
Advertisement
U.S. Markets close in 4 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

OncoSec Medical Incorporated (ONCS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7000-0.0200 (-1.16%)
As of 11:05AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.7200
Open1.7000
Bid1.6900 x 1800
Ask1.7100 x 1100
Day's Range1.6900 - 1.7200
52 Week Range1.6500 - 8.1600
Volume72,088
Avg. Volume231,793
Market Cap67.556M
Beta (5Y Monthly)2.29
PE Ratio (TTM)N/A
EPS (TTM)-1.7080
Earnings DateDec 11, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.75
  • PR Newswire

    OncoSec Provides Business Update

    OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer, today announced that Chris Twitty, Ph.D., Chief Scientific Officer, will be stepping down to pursue a new opportunity with a private oncology company.

  • Benzinga

    5 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Williams Industrial Services The Trade: Williams Industrial Services Group Inc. (NYSE: WLMS) Director Nelson Obus acquired

  • Benzinga

    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-

Advertisement
Advertisement